(Q37820920)

English

Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.

scientific article

Statements

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit